semaglutide off label use Edit for clarity: THIS POST IS RESPONDING TO THE RECENT UPTICK IN DEMAND FOR OZEMPIC FOR VANITY-RELATED WEIGHT LOSS, NOT CLINICAL REASONS, DUE TO SOCIAL MEDIA. In 2017, the FDA approved Ozempic ( Off-label prescription of diabetes drug

Some states have covered GLP-1 therapy for obesity, while others have narrowed or ended coverage because of cost

Direct GLP-1 receptor effects on genital tract tissues: limited support for a direct vaginal target Mechanistic caution is warranted because direct GLP-1 receptor expression in vaginal tissue appears low by large transcriptomic resources

Review BMI, diagnosis, and continuation criteria

Warfarin users need more frequent INR monitoring

The big difference between GLP-1 and Ozempic is that the molecular structure of Ozempic is modified just slightly to improve its longevity in the body and decrease the rate at which its broken down